Opko Health, Inc. Acquires PROLOR Biotech (PBTH) for $480 Million
4/24/2013 7:37:46 AM
More...
|
PROLOR Biotech (PBTH) Receives Notice of Allowance For New U.S. Patent Covering Long-Acting Coagulation Factors VII and IX
4/8/2013 10:13:03 AM
More...
|
PROLOR Biotech (PBTH) Receives Notice of Allowance for New U.S. Patent Covering Methods for Decreasing Body Fat With hGH-CTP
3/5/2013 10:02:01 AM
More...
|
PROLOR Biotech (PBTH)'s Longer-Acting Human Growth Hormone Receives Orphan Drug Designation in Europe
2/13/2013 9:13:15 AM
More...
|
PROLOR Biotech (PBTH) to Present New Preclinical Data on Its Long-Acting Clotting Factor VIIa at Leading European Scientific Conference
2/6/2013 9:51:06 AM
More...
|
PROLOR Biotech (PBTH) Receives Notice of Allowance for New U.S. Patent Covering Broad Applications of its CTP Platform for Long Acting Therapeutic Proteins
1/7/2013 10:13:54 AM
More...
|
PROLOR Biotech (PBTH) to Present at Oppenheimer 23rd Annual Healthcare Conference
12/10/2012 10:10:22 AM
More...
|
PROLOR Biotech (PBTH) to Present Preclinical Data on Its Long-Acting Clotting Factor Vlla at 2012 American Society of Hematology Annual Meeting
12/7/2012 9:06:24 AM
More...
|
New Patent Covering PROLOR Biotech (PBTH)'s Reversible-Pegylation Platform Technology is Allowed by U.S. Patent Office
11/13/2012 10:14:36 AM
More...
|
PROLOR Biotech (PBTH) to Present Data on Its Long-Acting Human Growth Hormone at Congress of the GRS and IGF Society
10/18/2012 10:48:54 AM
More...
|
|